Densitometric evaluation might prevent failure of knee artroplasty for aseptic loosening

References

1. ↵
   1. Järvenpää J,
   2. Soininvaara T,
   3. Kettunen J,
   4. Miettinen H,
   5. Kröger H

   (2014) Changes in bone mineral density of the distal femur after total knee arthroplasty: a 7-year DEXA follow-up comparing results between obese and nonobese patients. Knee 21:232–235.

   OpenUrl
2. ↵
   1. Jiang Y,
   2. Jia T,
   3. Wooley PH,
   4. Yang SY

   (2013) Current research in the pathogenesis of aseptic implant loosening associated with particulate wear debris. Acta Orthop Belg 79:1–9.

   OpenUrlPubMed
3. ↵
   1. Randelli F,
   2. Banci L,
   3. Favilla S,
   4. Maglione D,
   5. Aliprandi A

   (2013) Radiographically undetectable periprosthetic osteolysis with ASR implants: the implication of blood metal ions. J Arthroplasty 28:1259–1264.

   OpenUrlCrossRefPubMed
4. ↵
   1. Wei J,
   2. Cai X,
   3. Wang Y,
   4. Chen H,
   5. Zhang B

   (2010) [Mechanisms, prevention, and treatments of prosthetic aseptic loosening]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24:296–300, Chinese.

   OpenUrlPubMed
5. ↵
   1. Aro HT,
   2. Alm JJ,
   3. Moritz N,
   4. Mäkinen TJ,
   5. Lankinen P

   (2012) Low BMD affects initial stability and delays stem osseointegration in cementless total hip arthroplasty in women: a 2-year RSA study of 39 patients. Acta Orthop 83:107–114.

   OpenUrlCrossRefPubMed
6. ↵
   1. Alm JJ,
   2. Mäkinen TJ,
   3. Lankinen P,
   4. Moritz N,
   5. Vahlberg T,
   6. Aro HT

   (2009) Female patients with low systemic BMD are prone to bone loss in Gruen zone 7 after cementless total hip arthroplasty. Acta Orthop 80:531–537.

   OpenUrlPubMed
7. ↵
   1. Holi MS,
   2. Radhakrishnan S

   (2004) Estimation Of Low Bone Mass For The Assessment Of Osteoporosis Fracture Risk In Indian Men And Women Using Quantitative Ultrasound And Dual Energy X-Ray Absorptiometry. J Mech Med Biol 4:47.

   OpenUrl
8. ↵
   1. Frediani B,
   2. Acciai C,
   3. Falsetti P,
   4. Baldi F,
   5. Filippou G,
   6. Siagkri C,
   7. et al.

   (2006) Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk. Calcif Tissue Int 79:223–229.

   OpenUrlPubMed
9. ↵
   1. Prieto-Alhambra D,
   2. Javaid MK,
   3. Judge A,
   4. Murray D,
   5. Carr A,
   6. Cooper C,
   7. et al.

   (2011) Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. BMJ 343:d7222.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Prieto-Alhambra D,
    2. Lalmohamed A,
    3. Abrahamsen B,
    4. Arden NK,
    5. de Boer A,
    6. Vestergaard P,
    7. et al.

    (2014) Oral bisphosphonate use and total knee/hip implant survival: validation of results in an external population-based cohort. Arthritis Rheumatol 66:3233–3240.

    OpenUrl
11. ↵
    1. Lin T,
    2. Yan SG,
    3. Cai XZ,
    4. Ying ZM

    (2012) Bisphosphonates for periprosthetic bone loss after joint arthroplasty: a meta-analysis of 14 randomized controlled trials. Osteoporos Int 23:1823–1834.

    OpenUrlCrossRefPubMed
12. ↵
    1. Saviola G,
    2. Abdi-Ali L,
    3. Povino MR

    (2015) Clodronate: Old Drug, New Uses. J Biol Regul Homeost Agents 29:719–722.

    OpenUrl
13. ↵
    1. Trevisan C,
    2. Ortolani S,
    3. Romano P,
    4. Isaia G,
    5. Agnese L,
    6. Dallari D,
    7. et al.

    (2010) Decreased periprosthetic bone loss in patients treated with clodronate: a 1-year randomized controlled study. Calcif Tissue Int 86:436–446.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Hilding M,
    2. Aspenberg P

    (2006) Postoperative clodronate decreases prosthetic migration:4-year follow-up of a randomized radiostereometric study of 50 total knee patients. Acta Orthop 77:912–916.

    OpenUrlPubMedWeb of Science
15. ↵
    1. Muratore M,
    2. Quarta E,
    3. Quarta L,
    4. Calcagnile F,
    5. Grimaldi A,
    6. Orgiani MA,
    7. et al.

    (2012) Ibandronate and cementless total hip arthroplasty: densitometric measurement of periprosthetic bone mass and new therapeutic approach to the prevention of aseptic loosening. Clin Cases Miner Bone Metab 9:50–55.

    OpenUrlPubMed